Bosulif 100 mg Film-Coated Tablets: Uses and Safety
Quick summary: Bosulif® (bosutinib) is a prescription medicine used for Philadelphia chromosome-positive chronic myeloid leukemia (CML). This guide explains the tablet strength, how it is commonly taken with food, the side effects mentioned in...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary: Bosulif® (bosutinib) is a prescription medicine used for Philadelphia chromosome-positive chronic myeloid leukemia (CML). This guide explains the tablet strength, how it is commonly taken with food, the side effects mentioned in the source content, and the main safety points to review with a healthcare professional.
Important: Always follow the official patient leaflet and your oncology team’s instructions for your specific treatment plan.
Medical disclaimer: This article is for general information only and does not replace advice from a doctor, pharmacist, or the official product leaflet. It does not provide personal diagnosis or treatment recommendations.
What Bosulif 100 mg film-coated tablets are used for
Bosulif® contains bosutinib and is used in patients with Philadelphia chromosome-positive chronic myeloid leukemia (CML). The original content describes it as an important treatment option for this condition.
Because CML treatment is individualized, the exact role of Bosulif in a care plan should be confirmed by the prescribing oncology team.
How Bosulif is usually taken
The source content states that Bosulif is taken with food. Taking it with food is described as helping absorption and reducing stomach-related side effects.
The tablet should be swallowed whole. The original content also notes that, if swallowing is difficult, it may be mixed with applesauce or yogurt. If this applies, the patient should verify the instructions on the official leaflet or with a pharmacist.
It is also described as a medicine that should be taken at the same time each day to help maintain consistent levels in the body.
Dosing information mentioned in the source
The original content gives the following general dosing information:
- Newly diagnosed patients: a typical starting dose of 400 mg daily
- Resistance or intolerance: the dose may be increased to 500 mg daily
- Maximum dose mentioned: 600 mg daily
These details are presented as general information only. The actual dose, timing, and any adjustments must be determined by the prescribing clinician based on response and tolerability.
How Bosulif is prescribed and monitored
Bosulif is prescribed by healthcare providers, typically in oncology settings, after reviewing the patient’s health history and CML status.
The source content emphasizes that patients should have screening before treatment and regular monitoring during therapy. It specifically mentions blood counts and liver function checks as part of follow-up care.
Patients should also be given education about adherence and what to expect during treatment.
Common side effects listed in the source
The original content lists several side effects that may occur with Bosulif 100 mg film-coated tablets:
- Diarrhea, nausea, and vomiting
- Fatigue and dizziness
- Bone marrow suppression, which may lead to anemia or a higher risk of infection
- Fluid retention, including swelling in the hands and feet
- Changes in liver function
Not every patient will experience these effects, and some symptoms may need medical review. Any new, severe, or persistent symptom should be discussed with a healthcare professional.
Is Bosulif chemotherapy?
The source content says Bosulif is not traditional chemotherapy. It is described as a tyrosine kinase inhibitor, which works differently from conventional chemotherapy medicines.
This distinction may help patients understand why treatment plans, monitoring, and side effect patterns can differ from standard chemotherapy.
What patients should know before taking Bosulif
Before treatment begins, the original content highlights several points to review with the care team:
- Tell the doctor about existing health conditions, especially liver disease, heart conditions, or a history of infections.
- Discuss pregnancy and breastfeeding, as the source warns against use during pregnancy and breastfeeding.
- Ask about possible interactions with other medicines.
- Keep all follow-up appointments for monitoring and safety checks.
These points are important because treatment safety depends on the full medical picture, not just the tablet strength.
Cost and access considerations
The source content notes that the cost of Bosulif 100 mg film-coated tablets can vary depending on insurance coverage, pharmacy location, and patient assistance programs.
If cost is a concern, the article suggests checking insurance coverage and asking the healthcare team or pharmacy about available support options.
Helpful questions to ask the doctor or pharmacist
If you are reviewing Bosulif 100 mg tablets, these questions may help you confirm the details that matter most:
- What is the exact dose and schedule for this prescription?
- Should the tablet be taken with a meal every time?
- What monitoring tests are needed during treatment?
- Which side effects should be reported right away?
- Are there any medicine or food interactions to avoid?
Safety reminder
Do not change how Bosulif is taken, skip monitoring, or make dose decisions on your own. If symptoms are severe, unusual, or worsening, contact a healthcare professional promptly. For the most accurate instructions, always check the official leaflet and your prescriber’s advice.
Frequently asked questions
▸ What is Bosulif used to treat?
Bosulif is used for Philadelphia chromosome-positive chronic myeloid leukemia (CML), according to the source content.
▸ Is bosutinib 100 mg used for CML?
Yes. The source content states that bosutinib 100 mg is used in the treatment of chronic myeloid leukemia, especially when the Philadelphia chromosome is present.
▸ Does Bosulif cause weight gain?
Weight gain is not described as a common side effect in the source content. However, fluid retention may cause temporary weight changes.
▸ What foods should be avoided with Bosulif?
The source content does not list specific foods to avoid. It does say Bosulif should be taken with food, and it is sensible to confirm dietary guidance with the prescriber or pharmacist.
▸ Is Bosulif considered chemotherapy?
No. The source content describes Bosulif as a tyrosine kinase inhibitor rather than traditional chemotherapy.
▸ What should be checked before starting treatment?
The source content highlights screening for health conditions, review of other medicines, and monitoring plans such as blood counts and liver function tests.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
- Bosulif (bosutinib) official prescribing information
- NHS: Chronic myeloid leukaemia
- Cancer Research UK: Chronic myeloid leukaemia (CML)
To improve this article with specific references, add a custom field named _aio_sources in the post editor and write one source per line using: Source title|Source URL.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.